{"id":802098,"date":"2026-04-14T13:18:01","date_gmt":"2026-04-14T13:18:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=802098"},"modified":"2026-04-14T13:18:01","modified_gmt":"2026-04-14T13:18:01","slug":"immunohistochemistry-market-to-reach-514-billion-by-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/immunohistochemistry-market-to-reach-514-billion-by-2030_802098.html","title":{"rendered":"Immunohistochemistry Market to Reach $5.14 Billion by 2030"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1776180878.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Immunohistochemistry Market to Reach $5.14 Billion by 2030\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1776180878.jpg\" alt=\"Immunohistochemistry Market to Reach $5.14 Billion by 2030\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Immunohistochemistry Market by Product &#038; Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) &#8211; Global Forecast to 2030<\/div>\n<p style=\"text-align: justify;\">According to MarketsandMarkets&trade;, the global <strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/immunohistochemistry-market-121632939.html?utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Immunohistochemistry (IHC) Market<\/a><\/strong> is projected to grow from <strong>USD 3.55 billion in 2025 to USD 5.14 billion by 2030<\/strong>, registering a <strong>CAGR of 7.6%<\/strong> during the forecast period. Market growth is driven by increasing demand for advanced diagnostic techniques, particularly in oncology, along with favorable reimbursement policies supporting wider adoption of IHC testing.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure: <a rel=\"nofollow\" name=\"www_marketsandmarkets_com_pdfdownlo\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=121632939&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=121632939<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Browse<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>794 <\/strong>Market Data Tables<\/li>\n<li><strong>65 <\/strong>Figures<\/li>\n<li><strong>563 <\/strong>Pages and in-depth TOC on<strong> &#8220;<\/strong> <strong>Immunohistochemistry Market <strong>&#8211; Global Forecast to 2030&rdquo;.<\/strong><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The comprehensive reimbursement coverage in developed regions is significantly reducing patient out-of-pocket expenses, thereby increasing test volumes and driving demand for IHC instruments and reagents. However, inconsistencies in reimbursement frameworks across regions continue to pose challenges, potentially impacting the adoption of advanced and high-cost diagnostic solutions.<\/p>\n<p style=\"text-align: justify;\"><strong>Key Market Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">By product &amp; service, the <strong>kits segment<\/strong> is expected to register the highest growth during the forecast period. This growth is driven by a notable shift toward standardized, ready-to-use solutions among diagnostic laboratories, hospitals, and research institutions. Integrated kits with pre-validated components streamline workflows, reduce manual intervention, and enhance reproducibility and efficiency&mdash;critical factors for both clinical diagnostics and research applications.<\/p>\n<p style=\"text-align: justify;\"><strong>End User Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">By end user, <strong>hospitals &amp; diagnostic laboratories<\/strong> accounted for the largest share of the immunohistochemistry market in 2024. This dominance is attributed to the essential role of IHC in diagnosing a wide range of diseases, particularly cancer, infectious diseases, and autoimmune disorders. IHC remains a gold standard for identifying protein biomarkers, enabling precise disease characterization and supporting targeted therapy decisions. The increasing global burden of cancer and the growing trend of hospitals establishing in-house diagnostic capabilities are further driving segment growth.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=121632939&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=121632939<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Regional Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">The <strong>Asia Pacific<\/strong> region accounted for the largest share of the immunohistochemistry market in 2024. Growth in this region is driven by rising healthcare investments, expanding access to diagnostic services, and increasing incidence of chronic diseases such as cancer. Government initiatives to strengthen healthcare infrastructure, along with the rapid expansion of private diagnostic laboratories and contract research organizations, are further supporting market growth. Additionally, countries such as Singapore and Thailand are emerging as key hubs for medical tourism, boosting demand for advanced diagnostic technologies.<\/p>\n<p style=\"text-align: justify;\"><strong>Competitive Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\">The immunohistochemistry market is highly competitive, with leading players focusing on innovation, strategic collaborations, and expansion initiatives. Key companies operating in this market include F. Hoffmann-La Roche Ltd, Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Bio-Techne, Becton, Dickinson and Company, Takara Bio Inc., PHC Holdings Corporation, Enzo Biochem Inc., Sino Biological, Inc., OriGene Technologies, Inc., Cell Signaling Technology, Inc., Bio SB, Miltenyi Biotec, Sakura Finetek, EagleBio, Biocare Medical LLC, Elabscience BioInnovation Inc., Bio-Genex, Diagnostic BioSystems Inc., Histo-Line Laboratories, Rockland Immunochemicals, Inc., and CANDOR Bioscience GmbH, among others.<\/p>\n<p style=\"text-align: justify;\">As precision diagnostics and personalized medicine continue to advance, the immunohistochemistry market is poised for sustained growth, supported by technological innovation, increasing disease burden, and expanding global access to advanced diagnostic solutions.<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=703&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">In Vitro Diagnostics Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=436&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Immunoassay Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=immunohistochemistry-market-to-reach-514-billion-by-2030\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/immunohistochemistry-market-121632939.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/immunohistochemistry-market-121632939.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=immunohistochemistry-market-to-reach-514-billion-by-2030\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunohistochemistry Market by Product &#038; Service (Antibodies (Type (Primary), Clonality (Monoclonal), Regulatory Class, Reagents, Kits, Instruments (Stainers), Software)), Application (Diagnostics (Cancer), Research, Forensics) &#8211; Global Forecast to 2030 According to MarketsandMarkets&trade;, the global Immunohistochemistry (IHC) Market is projected to grow &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/immunohistochemistry-market-to-reach-514-billion-by-2030_802098.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,404],"tags":[],"class_list":["post-802098","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/802098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=802098"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/802098\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=802098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=802098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=802098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}